RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity (Q91173398)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

title

RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Ivan Topisirovic

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Ola Larsson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

9

Galina Selivanova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

author name string

Johannes Ristau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Vincent van Hoef

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Jiawei Zhu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Bo-Jhih Guan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Shuo Liang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Maria Hatzoglou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

publication date

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

published in

Cell Death and Disease

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

page(s)

845

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

Coping with stress: multiple ways to activate p53.

20 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Reverting p53 activation after recovery of cellular stress to resume with cell cycle progression

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Unravelling mechanisms of p53-mediated tumour suppression

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Mutational landscape and significance across 12 major cancer types

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Pharmacological reactivation of p53 as a strategy to treat cancer.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

SAR405838: an optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

PRIMA-1Met suppresses colorectal cancer independent of p53 by targeting MEK

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH/ROS balance

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

CRISPR-Cas9-based target validation for p53-reactivating model compounds.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylation

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Coping with stress: eIF2 kinases and translational control

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

The scanning mechanism of eukaryotic translation initiation

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Regulation of translation initiation in eukaryotes: mechanisms and biological targets

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Mechanism of activation of the double-stranded-RNA-dependent protein kinase, PKR: role of dimerization and cellular localization in the stimulation of PKR phosphorylation of eukaryotic initiation factor-2 (eIF2).

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Regulation of protein synthesis by heme-regulated eIF-2 alpha kinase

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Translational regulation of GCN4 and the general amino acid control of yeast

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Structural and Functional Analysis of the GADD34:PP1 eIF2α Phosphatase

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

A Unique ISR Program Determines Cellular Responses to Chronic Stress.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

CHOP is a multifunctional transcription factor in the ER stress response

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Multiplex genome engineering using CRISPR/Cas systems

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

p53-directed translational control can shape and expand the universe of p53 target genes.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Translation inhibitors induce cell death by multiple mechanisms and Mcl-1 reduction is only a minor contributor

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Global translational responses to oxidative stress impact upon multiple levels of protein synthesis.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

mTOR Signaling in Growth, Metabolism, and Disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Signaling pathways involved in the regulation of mRNA translation.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

p53 Isoforms: An Intracellular Microprocessor?

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Cancer-specific mutations in p53 induce the translation of Δ160p53 promoting tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

The small molecule ISRIB reverses the effects of eIF2α phosphorylation on translation and stress granule assembly

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B.

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

The eIF2α kinases: their structures and functions

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Endoplasmic reticulum stress stimulates p53 expression through NF-κB activation

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (P

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

eIF2α phosphorylation bypasses premature senescence caused by oxidative stress and pro-oxidant antitumor therapies

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

PRIMA-1MET induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Co-ordinated regulation of translation following DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

RITA enhances irradiation-induced apoptosis in p53-defective cervical cancer cells via upregulation of IRE1α/XBP1 signaling

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

Divergent effects of PERK and IRE1 signaling on cell viability

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

IRE1 signaling affects cell fate during the unfolded protein response

1 reference

https://api.crossref.org/works/10.1038%2FS41419-019-2074-3

7 January 2021

10.1038/S41419-019-2074-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31699971%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

PubMed publication ID

31699971

1 reference